NCT04092712View on ClinicalTrials.gov

Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

September 11, 2019

Study Completion Date

September 20, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]-CTP-543

Single dose of radiolabeled CTP-543 (approximately 75 μCi) administered as an oral solution

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Lead Sponsor

Concert Pharmaceuticals

Collaborators (1)

All Listed Sponsors

collaborator

Celerion

INDUSTRY

lead

Concert Pharmaceuticals

INDUSTRY